Advertisement
Research Article| Volume 55, ISSUE 2, P174-179, September 20, 2006

Risk factors for clinically diagnosed uterine fibroids in women around menopause

      Abstract

      Objective

      We analysed the risk factors for clinically diagnosed uterine fibroids in women attending menopause clinics in Italy.

      Methods

      Between 1997 and 2003 we conducted a large cross-sectional study on the characteristics of women around menopause attending a network of first-level outpatient menopause clinics in Italy for general counselling about menopause or treatment of menopausal symptoms. A total of 85,967 non-hysterectomized women not reporting myomectomy entered the study; 2239 had a diagnosis of uterine fibroids. A woman was defined as having uterine fibroids if she had at gynecological examination an enlarged uterus (2 months of gestation or more) and a clinical diagnosis of fibroids. In 769 cases was performed in ultrasound examination which confirmed the diagnosis.

      Results

      In comparison with women with a body mass index (BMI) <22, the multivariate ORs for BMI 26 or more were 1.30 (95% CI, 1.09–1.55) for cases with clinical diagnosis, and 1.29 (95% CI, 1.01–1.45) for women with ultrasonographic diagnosis. In comparison with premenopausal women, the multivariate OR for clinically detected fibroids was 0.63 (95% CI, 0.55–0.72) for post-menopausal ones. The risk of fibroids was lower in parous women than in nulliparous ones, and the risk decreased with number of births regardless the type of diagnosis.

      Conclusion

      This study confirms in a large sample that parity is the main protective factor for the development of fibroids. Overweight increases the risk.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vollenhoven B.
        Introduction: the epidemiology of uterine leiomyomas.
        Baillieres Clin Obstet Gynaecol. 1998; 12: 169
        • Marshall L.M.
        • Spiegelman D.
        • Goldman M.B.
        • et al.
        A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.
        Fertil Steril. 1998; 70: 432-439
        • Faerstein E.
        • Szklo M.
        • Rosenshein N.
        Risk factors for uterine leiomyoma: a practice-based case-control study. I. African–American heritage, reproductive history, body size, and smoking.
        Am J Epidemiol. 2001; 153: 1-10
        • Marshall L.M.
        • Spiegelman D.
        • Manson J.E.
        • et al.
        Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking.
        Epidemiology. 1998; 9: 511-517
        • Schwartz S.M.
        Invited commentary: studying the epidemiology of uterine leiomyomata—past, present, and future.
        Am J Epidemiol. 2001; 153: 27-29
        • Baird D.D.
        • Dunson D.B.
        • Hill M.C.
        • Cousins D.
        • Schectman J.M.
        High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.
        Am J Obstet Gynecol. 2003; 188: 100-107
        • Chen C.R.
        • Buck G.M.
        • Courey N.G.
        • Perez K.M.
        • Wactawski-Wende J.
        Risk factors for uterine fibroids among women undergoing tubal sterilization.
        Am J Epidemiol. 2001; 153: 20-26
        • Parazzini F.
        • La Vecchia C.
        • Negri E.
        • Cecchetti G.
        • Fedele L.
        Epidemiologic characteristics of women with uterine fibroids: a case-control study.
        Obstet Gynecol. 1988; 72: 853-857
        • Ross R.K.
        • Pike M.C.
        • Vessey M.P.
        • Bull D.
        • Yeates D.
        • Casagrande J.T.
        Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.
        Br Med J. 1986; 293: 359-362
        • Parazzini F.
        • Negri E.
        • La Vecchia C.
        • Chatenoud L.
        • Ricci E.
        • Guarnerio P.
        Reproductive factors and risk of uterine fibroids.
        Epidemiology. 1996; 7: 440-442
        • Wise L.A.
        • Palmer J.R.
        • Harlow B.
        • et al.
        Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African–American women: a prospective study.
        Am J Epidemiol. 2004; 159: 113-123
        • Chiaffarino F.
        • Parazzini F.
        • La Vecchia C.
        • Marsico S.
        • Surace M.
        • Ricci E.
        Use of oral contraceptives and uterine fibroids: results from a case-control study.
        Br J Obstet Gynaecol. 1999; 106: 857-860
        • Chiaffarino F.
        • Parazzini F.
        • La Vecchia C.
        • Ricci E.
        • Crosignani P.G.
        Oral contraceptive use and benign gynecologic conditions.
        Contraception. 1998; 57: 11-18
      1. Royal College of General Practitioners. Oral contraceptives and health. An interim report from the oral contraceptive study of the Royal College of General Practitioners. London: Pitman Medical Publishing; 1974.

        • Parazzini F.
        • Negri E.
        • La Vecchia C.
        • Fedele L.
        • Rabaiotti M.
        • Luchini L.
        Oral contraceptive use and risk of uterine fibroids.
        Obstet Gynecol. 1992; 79: 430-433
        • Wise L.A.
        • Palmer J.R.
        • Spiegelman D.
        • et al.
        Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women.
        Epidemiology. 2005; 16: 346-354
        • Lumbiganon P.
        • Rugpao S.
        • Phandhu-fung S.
        • Laopaiboon M.
        • Vudhikamraksa N.
        • Werawatakul Y.
        Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: A multicentre case-control study.
        Br J Obstet Gynaecol. 1996; 103: 909-914
        • Romieu I.
        • Walker A.M.
        • Jick S.
        Determinants of uterine fibroids.
        Post Marketing Surveillance. 1991; 5: 119-133
        • Faerstein E.
        • Szklo M.
        • Rosenshein N.B.
        Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation.
        Am J Epidemiol. 2001; 153: 11-19
        • Summers W.E.
        • Watson R.L.
        • Wooldridge W.H.
        • Langford H.G.
        Hypertension, obesity, and fibromyomata uteri, as a syndrome.
        Arch Intern Med. 1971; 128: 750-754
        • Parazzini F.
        • Chiaffarino F.
        • Polverino G.
        • Chiantera V.
        • Surace M.
        • La Vecchia C.
        Uterine fibroids risk and history of selected medical conditions linked with female hormones.
        Eur J Epidemiol. 2004; 19: 249-253
        • Marshall L.M.
        • Spiegelman D.
        • Barbieri R.L.
        • et al.
        Variation in the incidence of uterine leiomyoma in black and white women by age and race.
        Obetet Gynecol. 1997; 90: 967-973
      2. Pasetto N, Giacomello F, Patologia benigna dell’utero. La clinica Ostetrica e Ginecologica Candiani GB. In: Danesino V, Gastaldi A, eds. Masson; 1996, p. 1521.

        • Progetto Menopausa Italia Study Group
        Determinants of hysterectomy and oophorectomy in women attending menopause clinics in Italy.
        Maturitas. 2000; 36: 19-25
        • Progetto Menopausa Italia Study Group
        Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy.
        Br J Obstet Gynaecol. 2003; 110: 59-63
        • Baker R.J.
        • Nelder J.A.
        The GLIM system. Release 3.
        Numerical Algorithms Group, Oxford1978
        • La Vecchia C.
        • Decarli A.
        • Negri E.
        • Ferraroni M.
        • Pagano R.
        Height and the prevalence of chronic disease.
        Rev Epidemiol Sante Publ. 1992; 40: 6-14
        • Ang W.C.
        • Farrell E.
        • Vollenhoven B.
        Effect of hormone replacement therapies and selective estrogen receptor modulators in post-menopausal women with uterine leiomyomas: a literature review.
        Climacteric. 2001; 4: 284-292
        • Colacurci N.
        • De Franciscis P.
        • Mele D.
        • Palermo M.
        • Del Vecchio W.
        Effects of hormone replacement therapy on post-menopausal uterine myoma.
        Maturitas. 2000; 29: 167-173
        • Sener A.B.
        • Seckin N.C.
        • Ozmen S.
        • Gokmen O.
        • Dogu N.
        • Ekici E.
        The effects of hormone replacement therapy on uterine fibroids in post-menopausal women.
        Fertil Steril. 1996; 65: 354-357
        • Fedele L.
        • Parazzini F.
        • Luchini L.
        • Mezzopane R.
        • Tozzi L.
        • Villa L.
        Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study.
        Hum Reprod. 1995; 10: 1795-1796
        • Parazzini F.
        • La Vecchia C.
        • Franceschi S.
        • Negri E.
        • Cecchetti G.
        Risk factors for endometrioid, mucinous and serous benign ovarian cysts.
        Int J Epidemiol. 1989; 18: 108-112
        • Gruppo Italiano Studi Endometriosi
        • Parazzini F.
        Risk factors for pelvic endometriosis in women with pelvic pain or infertility.
        Eur J Obstet Gynecol Reprod Biol. 1999; 83: 195-199